Literature DB >> 1937776

Comparison of granule proteins from human polymorphonuclear leukocytes which are bactericidal toward Pseudomonas aeruginosa.

K R Wasiluk1, K M Skubitz, B H Gray.   

Abstract

Killing of Pseudomonas aeruginosa by a 55-kDa bactericidal protein (BP 55), a 30-kDa protein (BP 30), cathepsin G, elastase, and proteinase 3 has been compared. P. aeruginosa was resistant to killing by elastase and proteinase 3. BP 55 at a 50% lethal dose (LD50) of 0.23 micrograms of protein per 5 x 10(6) bacteria per ml killed P. aeruginosa and was far more active than BP 30 and cathepsin G. The LD50s of BP 30 and cathepsin G were 16.9 and 28.3 micrograms of protein per 5 x 10(6) bacteria per ml, respectively. Preincubation of BP 55 or BP 30 with lipopolysaccharide (LPS) from P. aeruginosa inhibited bactericidal activity. The N-terminal amino acid sequence of BP 55 and BP 30 revealed no relationship between the two proteins. However, a monoclonal antibody (AHN-15) reacted with both proteins by Western immunoblot. The bactericidal activity of cathepsin G toward P. aeruginosa appeared to be dependent on the availability of the active site of the enzyme; bactericidal activity was inhibited by phenylmethylsulfonyl fluoride (PMSF) and by the specific cathepsin G inhibitor, Z-Gly-Leu-Phe-CH2Cl. The enzyme and bactericidal activities of cathepsin G were also inhibited by LPS from P. aeruginosa. LPS from P. aeruginosa was shown to be a competitive inhibitor of the enzyme activity of cathepsin G. Elastase enzyme activity was also inhibited noncompetitively by LPS, but the enzyme was not bactericidal. We have concluded that all three bactericidal proteins (BP 55, BP 30, and cathepsin G) may bind to the LPS of the outer membrane of P. aeruginosa. It appears that the enzyme active site must be available for cathepsin G to kill P. aeruginosa and that the active site may be involved in the binding of cathepsin G to P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1937776      PMCID: PMC259016          DOI: 10.1128/IAI.59.11.4193-4200.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  Antibacterial activity of cationic proteins from human granulocytes.

Authors:  H Odeberg; I Olsson
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

2.  Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes.

Authors:  J Weiss; P Elsbach; I Olsson; H Odeberg
Journal:  J Biol Chem       Date:  1978-04-25       Impact factor: 5.157

Review 3.  Human leucocyte elastase and cathepsin G: structural and functional characteristics.

Authors:  J Travis; P J Giles; L Porcelli; C F Reilly; R Baugh; J Powers
Journal:  Ciba Found Symp       Date:  1979

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels.

Authors:  B R Oakley; D R Kirsch; N R Morris
Journal:  Anal Biochem       Date:  1980-07-01       Impact factor: 3.365

6.  CAP 37, a 37 kD human neutrophil granule cationic protein shares homology with inflammatory proteinases.

Authors:  H A Pereira; J K Spitznagel; J Pohl; D E Wilson; J Morgan; I Palings; J W Larrick
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

7.  Specific inhibition of human granulocyte elastase by cis-unsaturated fatty acids and activation by the corresponding alcohols.

Authors:  B M Ashe; M Zimmerman
Journal:  Biochem Biophys Res Commun       Date:  1977-03-07       Impact factor: 3.575

8.  Mechanisms for the microbicidal activity of cationic proteins of human granulocytes.

Authors:  H Odeberg; I Olsson
Journal:  Infect Immun       Date:  1976-12       Impact factor: 3.441

9.  Resistance of gram-negative bacteria to purified bactericidal leukocyte proteins: relation to binding and bacterial lipopolysaccharide structure.

Authors:  J Weiss; S Beckerdite-Quagliata; P Elsbach
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

10.  Nonoxidative fungicidal mechanisms of mammalian granulocytes: demonstration of components with candidacidal activity in human, rabbit, and guinea pig leukocytes.

Authors:  R I Lehrer; K M Ladra; R B Hake
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

View more
  16 in total

1.  Human neutrophil azurocidin synergizes with leukocyte elastase and cathepsin G in the killing of Capnocytophaga sputigena.

Authors:  K T Miyasaki; A L Bodeau
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

Review 2.  Agents that increase the permeability of the outer membrane.

Authors:  M Vaara
Journal:  Microbiol Rev       Date:  1992-09

3.  Paucimannose-Rich N-glycosylation of Spatiotemporally Regulated Human Neutrophil Elastase Modulates Its Immune Functions.

Authors:  Ian Loke; Ole Østergaard; Niels H H Heegaard; Nicolle H Packer; Morten Thaysen-Andersen
Journal:  Mol Cell Proteomics       Date:  2017-06-19       Impact factor: 5.911

4.  Augmentation of oxidant injury to human pulmonary epithelial cells by the Pseudomonas aeruginosa siderophore pyochelin.

Authors:  B E Britigan; G T Rasmussen; C D Cox
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

Review 5.  Role of oxidants in microbial pathophysiology.

Authors:  R A Miller; B E Britigan
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

6.  Synthetic bactericidal peptide based on CAP37: a 37-kDa human neutrophil granule-associated cationic antimicrobial protein chemotactic for monocytes.

Authors:  H A Pereira; I Erdem; J Pohl; J K Spitznagel
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

7.  Bactericidal activities of synthetic human leukocyte cathepsin G-derived antibiotic peptides and congeners against Actinobacillus actinomycetemcomitans and Capnocytophaga sputigena.

Authors:  K T Miyasaki; A L Bodeau; J Pohl; W M Shafer
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

8.  Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.

Authors:  J Weiss; P Elsbach; C Shu; J Castillo; L Grinna; A Horwitz; G Theofan
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

9.  Characterization of bovine neutrophil antibacterial polypeptides which bind to Escherichia coli.

Authors:  L Litteri; D Romeo
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

10.  Synthetic peptides of human lysosomal cathepsin G with potent antipseudomonal activity.

Authors:  W M Shafer; M E Shepherd; B Boltin; L Wells; J Pohl
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.